People
With some shareholder opposition raised against the $74 billion acquisition of Celgene, the BMS board of directors is attempting to strengthen support of the deal ahead of the April 12 meeting.
Biotech and pharma companies make appointments to strengthen executive teams, with moves at Sanofi, Forma, Orchard, CLSA, Sangamo, and more.
As Scott Gottlieb prepares to step down from his role as commissioner of the U.S. Food and Drug Administration, he sat down with Politico to talk about his two years at the helm of the regulatory agency and what regrets he may be leaving behind.
The Society for Clinical Research Sites announced to attendees at its 2019 European Site Solutions Summit that SCALA Clinical Research is the winner of the European Site Patient Recruitment Innovation Award.
Recipharm has announced that its 2018 International Environmental Award will be presented to Dr. Bryan Brooks, Distinguished Professor in Environmental Science and Biomedical Studies at Baylor University in Waco, Texas.
Privately-held Swedish pharmaceutical company Lobsor Pharmaceuticals AB is eying the U.S. market for a potential treatment for neurodegenerative diseases such as Parkinson’s disease.
Arizona is not exactly the first place one thinks of when it comes to the life sciences. But, like many states and municipalities, Arizona and Phoenix, Arizona, are working hard to grow the life science industry. According to AZBio, bioscience companies in Arizona employed 25,686 people in 2016 in 1,310 individual businesses.
Biotech and pharma companies from across Europe and Asia provide updates on pipeline and business activities.
One year after spinning out from AstraZeneca’s MedImmune, Viela Bio is already anticipating filing a Biologics License Application with the U.S. Food and Drug Administration for its lead asset, inebilizumab.
For years, the biggest employers of science and engineering PhDs has been academic institutions. For example, according to the U.S. National Science Foundation (NSF)’s biennial Survey of Doctoral Recipients, academia employed 11 percent more PhDs than the private sector in 1997.
PRESS RELEASES